|B.Riley FBR, Inc.||George Zavoico, Ph.D.||646.885.5409 | firstname.lastname@example.org|
|Brookline Capital Markets||Kumaraguru Raja, PhD, MBA||646.462.4671 | email@example.com|
|Cantor Fitzgerald||Elemer Piros, Ph.D.||212.610.2416 | firstname.lastname@example.org|
|H.C. Wainwright||Andrew S. Fein||212.356.0546 | email@example.com|
|JMP Securities||Liisa A. Bayko||312.768.1785 | firstname.lastname@example.org|
|Oppenheimer & Co Inc.||Leland Gershell, MD, PhD||212.667.7189 | Leland.Gershell@opco.com|
|RBC Capital Markets||Brian Abrahams, MD||212.858.7066 | email@example.com|
Corbus Pharmaceuticals Holdings, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Corbus Pharmaceuticals Holdings, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Corbus Pharmaceuticals Holdings, Inc. or its management. Corbus Pharmaceuticals Holdings, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.